Medication info
Mirtol Tablets 20 mg (Telmisartan)

Mirtol Tablets 20 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›20mg / 1 tablet
Manufacturer / importer
Withus Pharm. Co., Ltd.
Appearance
White round tablets
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202500502 · Approved 2025.03.06 · Insurance code 660704000

Summary

Main use
Treatment of essential hypertension and prevention of cardiovascular disease in high-risk patients
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water, with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. After treatment is started, the maximum blood pressure-lowering effect is achieved in 4 ∼ 8 weeks when the dose is increased. This medication has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medication be administered orally at 80 mg once daily with water, with or without food. The effect of doses below 80 mg on reducing the risk of cardiovascular morbidity and mortality is unknown. When starting treatment with this medication to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medications may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Withus Pharm. Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and prevention of cardiovascular disease in high-risk patients

  • Essential hypertension
  • coronary artery disease
  • peripheral arterial disease
  • stroke
  • transient ischemic attack
  • clinical evidence of damage to end organs in high-risk diabetes
View approved original text

This medication helps to control blood pressure in patients with essential hypertension. It is also used to reduce the risk of myocardial infarction, stroke, and cardiovascular mortality in patients over 55 years of age who have a history of coronary artery disease, peripheral arterial disease, stroke, or high-risk diabetes. It is particularly effective in patients who cannot take ACE inhibitors. This medication plays an important role in overall risk reduction for cardiovascular diseases. Therefore, it can be used as a medication that aids in blood pressure management and improvement of cardiovascular health.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water, with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. After treatment is started, the maximum blood pressure-lowering effect is achieved in 4 ∼ 8 weeks when the dose is increased. This medication has an additional blood pressure-lowering effect when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that this medication be administered orally at 80 mg once daily with water, with or without food. The effect of doses below 80 mg on reducing the risk of cardiovascular morbidity and mortality is unknown. When starting treatment with this medication to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medications may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm to the fetus and newborn, so if pregnancy is confirmed, it should be discontinued immediately. Women who are pregnant or may become pregnant, as well as nursing mothers, should not take this medication. Patients with severe liver impairment, biliary obstruction, or cholestasis should not take this medication. Patients with allergic reactions or a history of hereditary angioedema should also avoid using this medication. In diabetic patients with moderate to severe renal impairment, it is prohibited to take this medication alongside certain other medications. Elderly patients, those with hyperkalemia, and patients with mild to moderate liver dysfunction should use this medication cautiously and may require dose adjustments. Caution is also necessary for patients with heart valve disease or ischemic heart disease. This drug has a blood-lowering effect, and excessive blood pressure reduction could lead to risks of myocardial infarction or stroke. Patients with weak kidney function or renal artery stenosis should also use this medication cautiously, as there is a risk of worsening renal function, and monitoring is needed. This medication may increase the blood pressure-lowering effect when taken with other antihypertensive medications. Regular monitoring of potassium levels is necessary due to the potential for hyperkalemia. Special caution is required when used with potassium-sparing diuretics or potassium supplements, as potassium levels can become dangerously high. This medication can lead to serious side effects such as liver dysfunction, jaundice, angioedema, renal failure, shock, syncope; if symptoms occur, it should be discontinued immediately and medical attention sought. Caution is needed while driving or operating machinery as there is a possibility of dizziness or fainting. This medication contains sorbitol and is not suitable for patients with fructose intolerance. Women who are pregnant or planning to become pregnant should not take this medication, and nursing mothers are also advised to avoid it. This medication is not recommended for children under 18 years of age as safety and efficacy have not been established. Overdose may result in hypotension, dizziness, acute renal failure; immediate medical treatment should be sought. This medication should be kept out of reach of children, and transferring to another container can jeopardize quality.

Side effects

  • Upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 81 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • taste disturbance
  • impaired liver function
  • liver dysfunction
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • elevated liver enzymes
  • increased serum creatine kinase
  • decreased hemoglobin
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • vertigo
  • palpitations
  • nausea
  • inadequate response
  • angioedema
  • shock
  • loss of consciousness
  • jaundice
  • anaphylaxis-like symptoms
  • interstitial pneumonia
  • rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly-closed container to prevent exposure to air or moisture. It is important to maintain a storage temperature between 1°C and 30°C at room temperature to ensure the drug's efficacy is safely preserved.

Appearance and packaging

Appearance

White round tablets

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.